Kane Biotech Inc (KNE_CDNX)
KNE_CDNX moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How KNE_CDNX actually reacts to news — the realized, point-in-time move the market made, measured across 85 labeled events over the last three years with zero look-ahead.
KNE_CDNX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 6% | 36 |
| 30-min | 0.00% | 22% | 37 |
| 60-min | 0.00% | 26% | 38 |
| to close | 0.00% | 25% | 40 |
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when KNE_CDNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to KNE_CDNX's baseline. Nothing else.
Recent KNE_CDNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Kane Biotech Announces $250,000 Insider Loan | Press release | GlobeNewswire | — | — | |
| Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026 | Press release | GlobeNewswire | — | — | |
| Kane Biotech to Host Commercial Update Webcast on September 16 | Press release | GlobeNewswire | — | — | |
| Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc. | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Second Quarter 2026 Financial Results | Press release | GlobeNewswire | — | — | |
| Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Engagement of DNA Advisors | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Results of Annual and Special Meeting of Shareholders | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces First Quarter 2026 Financial Results | Press release | GlobeNewswire | — | — | |
| Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | — | — | |
| Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms | Press release | GlobeNewswire | — | — | |
| Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal | Press release | GlobeNewswire | — | — | |
| Kane Biotech Expands Commercial Activities in the United States | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser | Press release | GlobeNewswire | — | — | |
| Kane Biotech Restarts Commercial Activities and Strengthens North American Management | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company | Press release | GlobeNewswire | — | — | |
| Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting | Press release | GlobeNewswire | — | — | |
| Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Third Quarter 2025 Financial Results | Press release | GlobeNewswire | — | — | |
| Kane Biotech Presents revyve® Data at Diabetic Foot and Southern Region Burn Conferences | Press release | GlobeNewswire | — | — | |
| Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser | Press release | GlobeNewswire | — | — | |
| Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray | Press release | GlobeNewswire | — | — | |
| Kane Biotech to Present revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Fall Conference | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Second Quarter 2025 Financial Results | Press release | GlobeNewswire | — | — | |
| Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences | Press release | GlobeNewswire | — | — | |
| Kane Biotech to Present at Advanced Wound Care Summit USA | Press release | GlobeNewswire | — | — | |
| Kane Biotech Provides Further Corporate Update | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces First Quarter 2025 Financial Results | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change | Press release | GlobeNewswire | — | — | |
| Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel | Press release | GlobeNewswire | — | — | |
| Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces $3,000,000 Private Placement Offering | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Third Quarter 2024 Financial Results | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel | Press release | GlobeNewswire | — | — | |
| Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024 | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel | Press release | GlobeNewswire | — | — | |
| Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement | Press release | GlobeNewswire | — | — | |
| Canadian Investment Regulatory Organization Trade Resumption - KNE | Press release | Canada Newswire | — | — | |
| Canadian Investment Regulatory Organization Trading Halt - KNE | Press release | Canada Newswire | — | — | |
| Kane Biotech Announces Agreement to Acquire FB Dermatology | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Exclusive Distribution Agreement With XSONX | Press release | GlobeNewswire | — | — | |
| Kane Biotech to Participate in a Multinational Corporate Collaboration Project | Press release | GlobeNewswire | — | — | |
| Kane Biotech Announces Attendance at Upcoming Wound Care Conferences | Press release | GlobeNewswire | +0.00% | -3.70% | |
| Kane Biotech Announces Exercise of Warrants | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations | Press release | GlobeNewswire | +0.00% | +3.33% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the KNE_CDNX section they belong to.
Where else KNE_CDNX is measured.
KNE_CDNX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BIOLASE INC (BIOL) | 85 | -2.09% | 28% |
| Cryo-Cell International, Inc. (CCEL) | 85 | 0.00% | 47% |
| Regen Biopharma, Inc. Common (RGBP) | 85 | 0.00% | 36% |
| UCB SA UNSP/ADR (UCBJY) | 85 | +0.00% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Kane Biotech Inc's median reaction calculated?
Every labeled KNE_CDNX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 85 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 22% of KNE_CDNX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does KNE_CDNX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.